[Federal Register Volume 68, Number 156 (Wednesday, August 13, 2003)]
[Notices]
[Page 48400]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-20557]



[[Page 48400]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel ``Biodefense and Emerging Infectious 
Diseases''.
    Date: August 26, 2003.
    Time: 11:30 a.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: 6700B Rockledge Drive, Bethesda, MD 20892 (Telephone 
Conference Call).
    Contact Person: Gregory P. Jarosik, Ph.D., Scientific Review 
Administrator, Scientific Review Program, Division of Extramaural 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, MSC 7616, Bethesda, MD 20892, 301-496-0695, 
[email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 6, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-20557 Filed 8-12-03; 8:45 am]
BILLING CODE 4140-01-M